Genesis Innovation Group
Overview
Genesis Innovation Group is a medical device development and commercialization company that partners with inventors, entrepreneurs, and medical device companies to develop innovative technologies that positively impact patient care and deliver better outcomes. They offer a platform of medical device development services from ideation to commercialization.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shoulder Innovations | Oct 2018 | Series A | Lead |
| Virtual Incision | Nov 2021 | Series C | - |
| Capitan Orthopedics, Inc. | Aug 2026 | Seed | Co-investor |
| HAPPE Spine | Nov 2025 | VC Round | Co-investor |
| NSite Medical | May 2021 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genesis Innovation Group based?
Genesis Innovation Group is headquartered in Grand Rapids, Michigan, United States.
When was Genesis Innovation Group founded?
Genesis Innovation Group was founded in 2013.
How many portfolio companies does Genesis Innovation Group have?
Genesis Innovation Group has 5 portfolio companies in Caplight's dataset.
What are some companies in Genesis Innovation Group's portfolio?
Portfolio companies visible on Caplight include Shoulder Innovations, Virtual Incision, Capitan Orthopedics, Inc., HAPPE Spine, NSite Medical.
What was Genesis Innovation Group's most recent investment shown here?
Genesis Innovation Group's most recent investment in this portfolio sample was in Capitan Orthopedics, Inc. in 2026.
What sectors does Genesis Innovation Group focus on?
Genesis Innovation Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Genesis Innovation Group focus on?
Genesis Innovation Group typically invests at the Early stage.
What is Genesis Innovation Group's AUM?
Genesis Innovation Group's assets under management are estimated between $0.0 and $50.0M.